Suppr超能文献

心脏移植后由心室辅助装置桥接的耐多药真菌性假性动脉瘤

Multidrug Resistant Mycotic Pseudoaneurysm following Cardiac Transplant Bridged by Ventricular Assistant Device.

作者信息

Aye C, Williams M, Horvath R

机构信息

Infection Management Unit, The Prince Charles Hospital, Brisbane, QLD 4032, Australia; School of Medicine, University of Queensland, Brisbane, QLD, Australia.

Department of Pharmacy, The Prince Charles Hospital, Brisbane, QLD 4032, Australia.

出版信息

Case Rep Infect Dis. 2017;2017:1402320. doi: 10.1155/2017/1402320. Epub 2017 Mar 13.

Abstract

Mycotic pseudoaneurysm of aorta following cardiac surgery is rare but is highly fatal if it is unrecognized and untreated. Here, we report a case of a 45-year-old male patient who presented with rapidly progressive multiple pseudoaneurysms of the ascending aorta infected with multidrug resistant (MDR) 5 weeks after cardiac transplantation, on a background of prior bridging therapy with left ventricular assistant device (LVAD). The patient was successfully treated with the newer cephalosporin, Ceftolozane/Tazobactam, in combination with surgery. This is the first reported case of mycotic pseudoaneurysm infected with MDR . This case also highlights the importance of high vigilance and timely multimodality treatment in the diagnosis and management of mycotic pseudoaneurysm following cardiac transplant, especially in patients who had LVAD.

摘要

心脏手术后发生的主动脉霉菌性假性动脉瘤较为罕见,但如果未被识别和治疗则具有很高的致死率。在此,我们报告一例45岁男性患者,该患者在心脏移植术后5周出现升主动脉多发快速进展性假性动脉瘤,感染了多重耐药菌(MDR),其前期接受过左心室辅助装置(LVAD)的桥接治疗。该患者通过使用新型头孢菌素头孢洛扎/他唑巴坦联合手术成功治愈。这是首例报道的感染多重耐药菌的霉菌性假性动脉瘤病例。该病例还凸显了在心脏移植术后霉菌性假性动脉瘤的诊断和管理中保持高度警惕并及时采取多模式治疗的重要性,尤其是对于接受过LVAD治疗的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a503/5366783/af0a732f5c66/CRIID2017-1402320.001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验